College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
Department of Microbiology, School of Preclinical Medicine, Airforce Medical University, Xi'an, Shaanxi, China.
Front Cell Infect Microbiol. 2022 Dec 12;12:881083. doi: 10.3389/fcimb.2022.881083. eCollection 2022.
Hantaan virus (HTNV) is the etiological pathogen of hemorrhagic fever with renal syndrome in East Asia. There are currently no effective therapeutics approved for HTNV and other hantavirus infections. We found that griffithsin (GRFT), an algae-derived lectin with broad-spectrum antiviral activity against various enveloped viruses, can inhibit the growth and spread of HTNV. experiments using recombinant vesicular stomatitis virus (rVSV) with HTNV glycoproteins as a model revealed that the GRFT inhibited the entry of rVSV-HTNV-G into host cells. In addition, we demonstrated that GRFT prevented authentic HTNV infection by binding to the viral -glycans. experiments showed that GRFT partially protected the suckling mice from death induced by intracranial exposure to HTNV. These results demonstrated that GRFT can be a promising agent for inhibiting HTNV infection.
汉坦病毒(HTNV)是东亚地区肾综合征出血热的病原体。目前尚无针对 HTNV 和其他汉坦病毒感染的有效治疗方法。我们发现,具有广谱抗多种包膜病毒活性的海藻来源凝集素 griffithsin(GRFT)可以抑制 HTNV 的生长和扩散。使用带有 HTNV 糖蛋白的重组水疱性口炎病毒(rVSV)作为模型的实验表明,GRFT 抑制了 rVSV-HTNV-G 进入宿主细胞。此外,我们证明 GRFT 通过与病毒糖基结合来预防真正的 HTNV 感染。实验表明,GRFT 可部分保护乳鼠免受经颅内暴露于 HTNV 引起的死亡。这些结果表明,GRFT 可能是一种有前途的抑制 HTNV 感染的药物。